
浏览全部资源
扫码关注微信
1. 西安医科大学第一附属医院
2. 西安医科大学第二附属医院,西安,710061
3. ,西安,710004
纸质出版日期:1992-11-01
移动端阅览
[1]胡国瑛,王自法.肝癌栓塞治疗剂~(131)I-碘化油的制备和动物实验[J].核技术,1992(11):661-664.
Hu Guoying. Embolistic therapy agent of liver cancer: preparation of 131I - lipiodol and its animal experiment[J]. Nuclear techniques, 1992, (11): 661-664.
以丙酮为溶剂进行同位素交换反应制备
131
I-碘化油
操作简便
标记率可达95%以上。室温放置15d及高压灭菌后未见脱碘现象。γ照相显示
131
I-碘化油注入狗的肝动脉后
仅选择性地蓄积于注入动脉的供血区内
甲状腺及肺等其它部位未见核素蓄积。
131
I-碘化油在肝内的有效半衰期为4.92±0.66d。每毫升血液放射性仅为注入量的0.09±0.04%
提示
131
I-碘化油性能稳定
适宜临床应用。
Lipiodol was labelled with 131I using an iodine exchange reaction with acetone as solvent. The labelling rate was 95%. No dehalogenation was detected within 15 days at room temperature or after sterilization. Animal experiments showed that after hepatic arterial injection 131I -lipiodol was selectively accumulated in the embolized local area. No increased activity was observed in the thyroid
lung or other areas. The effective half - life in liver was 4. 92±0. 66 days. The blood radioactivity per ml was 0. 09±0. 04% of the injected dose . The results suggest that the 131I - lipiodol is very stable and suitable for clinical application.
0
浏览量
73
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621